Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 7, 1999, Pages 1621-1624

  Schmitz, Klaus ^a   Banditt, Peter ^a   Motschmann, Markus ^a   Meyer, Frank Peter ^a   Behrens Baumann, Wolfgang ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ABSORPTION; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CARBONIC ANHYDRASE INHIBITORS; CATARACT EXTRACTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; SULFONAMIDES; THIOPHENES;

EID: 0032977702     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Maren TH. Carbonic anhydrase: general perspectives and advances in glaucoma research. Drug Dev Res. 1987;10:255-276.
2. Sugrue MF. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocular Pharmacol Ther. 1996;12:363-376.
3. Biollaz J, Munafo A, Buclin T, et al. Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide. Eur J Clin Pharmacol. 1995;47:453-460.
4. Matuszewski BK, Constanzer ML, Woolf EJ, Au T, Haddix H. Determination of MK-507, a novel topically effective carbonic anhydrase inhibitor, and its de-ethylated metabolite in human whole blood, plasma and urine by high-performance liquid chromatography. J Chromatogr B. 1994;653:77-85.
5. Becker B. Decrease in intraocular pressure in man by carbonic anhydrase inhibitor, Diamox: a preliminary report. Am J Ophthalmol. 1954;37:13-15.
6. Dailey RA, Brubaker RF, Bourne WM. The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am J Ophthalmol. 1982;93:232-237.
7. Maren TH. Carbonic anhydrase: chemistry, physiology and inhibition. Physiol Rev. 1967;47:595-781.
8. Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Arch Ophthalmol. 1977;95:1378-1382.
9. Lichter PR, Neumann LP, Wheeler NC, et al. Patient tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol. 1978;85:495-502.
10. Maren TH. The development of topical carbonic anhydrase inhibitors. J Glaucoma. 1995;4:49-62.
11. Lippa EA, Carlson LE, Ehinger B, et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1992;110:495-499.
12. Strahlman E, Tipping R, Vogel R. The international dorzolamide study-group: a double-masked, randomized 1-year study comparing dorzolamide, timolol and betaxolol. Arch Ophthalmol. 1995;113: 1009-1016.
13. Maren TH, Jankowska L, Sanyal G, et al. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Exp Eye Res. 1983;36:457-480.
14. Lippa EA, Schuman JS, Higginbotham EJ, et al. MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology. 1991;98:308-313.
15. Sugrue MF, Waheed A, Sly WS, et al. A study of the in vitro inhibition of human carbonic anhydrase isoenzymes I, II and IV [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1993;34(4): S930. Abstract nr 1143.
16. Sears ML, Matsui ML, Muarkami M, et al. Localization of carbonic anhydrase mediated aqueous humor secretion to basolateral membranes of non-pigmented epithelium of ciliary processes [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1994;35(4):S1454. Abstract nr 931.
17. Hageman GS, Zhu XL, Wahedd A, Sly WS. Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. Proc Natl Acad Sci USA. 1991;88:2716-2720.
18. Brechue WF, Maren TH. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors. Invest Ophthalmol Vis Sci. 1993;34:2581-2587.
19. Harris A, Arend O, Arend S, Martin B. Effects of topical dorzolamide on retinal and retrobulbar hemodynamics. Acta Ophthalmol Scand. 1996;74:569-572.
20. Terashima H, Suzuki K, Kato K, Sugai N. Membrane-bound carbonic anhydrase activity in the rat corneal endothelium and retina. Jpn J Ophthalmol. 1996;40:142-153.
21. Watsky MA, Jablonski MM, Edelhauser HF. Comparison of conjunctival and corneal surface areas in rabbit and human. Curr Eye Res. 1988;7:483-486.